Anath A. Flugelman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anath A. Flugelman has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Adi Turgeman
Faculty of Medical and Health Sciences Tel‐Aviv University Tel Aviv Israel
1 shared publicationAlex Vilkin
Division of Gastroenterology Rabin Medical Center Petach‐Tikva Israel
1 shared publicationAnya Burton
National Cancer Registration and Analysis Service Bristol UK
1 shared publicationDafna Kutner
The Department of Community Medicine and Epidemiology Lady Davis Carmel Medical Center Haifa Israel
1 shared publication- Doron Boltin
Gastroenterology Division Rabin Medical Center Beilinson Hospital Petach Tikva Petah Tikva Israel
1 shared publication Elizabeth Half‐Onn
Technion‐Israel Institute of Technology Haifa Israel
1 shared publication
Latest Publications
- Open Access
- 23 March 2026
- Published by Wiley in Helicobacter
- Vol. 31 (2) , e70120
The Association of a Positive Fecal Immunochemical Test With the Risk of Gastroesophageal Cancer: An Age‐Sex‐ H. Pylori Exposure Matched Cohort Study and Cost‐Effectiveness Analysis
Background and Aims: We evaluated the association between Fecal Immunochemical Test (FIT) results and the risk of gastroesophageal cancer (GEC) in a matched cohort, as well as the cost‐effectiveness of a one‐time esophagogastroduodenoscopy (EGD) for individuals who tested FIT‐positive. Methods: We formed a cohort of individuals aged 50–75 years who underwent FIT testing at Clalit Health in Israel from 2016 to 2019. For each person with a positive FIT result, we matched three individuals with negative results by age, gender, and H. pylori exposure. We used adjusted hazard ratios (adjHRs) to assess the association between a positive FIT result and the risk of GEC within 36 months. We calculated the incremental cost‐effectiveness ratio (ICER) for a one‐time EGD costing USD 350 in individuals who tested positive for FIT, and considered it cost‐effective if below USD 50,000. Results: The study included 150,391 individuals (47.6% female, median age 62.4 years). During follow‐up, 202 cases of GEC were recorded: 0.17% in FIT‐positive individuals (64/37,709) and 0.12% in FIT‐negative individuals (138/112,682), adjHR 1.39 (95% CI 1.03–1.87). GEC was also associated with H. pylori exposure (adjHR 1.43, 95% CI 1.08–1.90) and immigration from high‐risk countries. A one‐time EGD demonstrated favorable cost‐effectiveness across various scenarios, with an ICER of USD 25,535/QALY. Conclusions: This matched‐cohort study suggests that individuals with a positive FIT may have an increased risk of GEC, comparable to that of established high‐risk populations. Adding a one‐time EGD to colonoscopy for FIT‐positive individuals may be a cost‐effective approach for healthcare systems that can accommodate such interventions.
- 23 March 2026
- Published by Wiley in Helicobacter
- Vol. 31 (2) , e70120
Open AccessThe Association of a Positive Fecal Immunochemical Test With the Risk of Gastroesophageal Cancer: An Age‐Sex‐ H. Pylori Exposure Matched Cohort Study and Cost‐Effectiveness Analysis
Background and Aims: We evaluated the association between Fecal Immunochemical Test (FIT) results and the risk of gastroesophageal cancer (GEC) in a matched cohort, as well as the cost‐effectiveness of a one‐time esophagogastroduodenoscopy (EGD) for individuals who tested FIT‐positive. Methods: We formed a cohort of individuals aged 50–75 years who underwent FIT testing at Clalit Health in Israel from 2016 to 2019. For each person with a positive FIT result, we matched three individuals with negative results by age, gender, and H. pylori exposure. We used adjusted hazard ratios (adjHRs) to assess the association between a positive FIT result and the risk of GEC within 36 months. We calculated the incremental cost‐effectiveness ratio (ICER) for a one‐time EGD costing USD 350 in individuals who tested positive for FIT, and considered it cost‐effective if below USD 50,000. Results: The study included 150,391 individuals (47.6% female, median age 62.4 years). During follow‐up, 202 cases of GEC were recorded: 0.17% in FIT‐positive individuals (64/37,709) and 0.12% in FIT‐negative individuals (138/112,682), adjHR 1.39 (95% CI 1.03–1.87). GEC was also associated with H. pylori exposure (adjHR 1.43, 95% CI 1.08–1.90) and immigration from high‐risk countries. A one‐time EGD demonstrated favorable cost‐effectiveness across various scenarios, with an ICER of USD 25,535/QALY. Conclusions: This matched‐cohort study suggests that individuals with a positive FIT may have an increased risk of GEC, comparable to that of established high‐risk populations. Adding a one‐time EGD to colonoscopy for FIT‐positive individuals may be a cost‐effective approach for healthcare systems that can accommodate such interventions.
- 9 March 2022
- Published by Wiley in International Journal of Cancer
- Vol. 150 (12) , 1968-1977
Correlation between cumulative mammographic density and age‐specific incidence of breast cancer: A biethnic study in Israel
Women with the most extensive breast density, have a 4- to 6-fold higher cancer risk than women with the lowest density. This cross-sectional study evaluated associations of cumulative mammographic density in two distinct ethnic groups with the respective age-specific breast cancer incidences in the population. The study compared four cohorts of 200 women each aged 35 to 49 and 50 to 74, representing Jewish and Arab ethnicity. Breast density measures were calculated from screening mammograms, using a thresholding software (Cumulus). Breast cancer specific incidence values were obtained from the National Cancer Registry. The percent mammographic density was lower for women aged 50 to 74 than 35 to 49 years, both for Jews: 11.7 vs 23.1 and for Arabs: 11.6 vs 18.3. In contrast, the cumulative density increased with age, from 37.30 to 181.24 in Jews, compared to 21.26 to 108.03 in Arabs. Similar trends in breast cancer incidence rates per 100 000 in the Israeli population were apparent, with an increase from 92.95 to 381.91 in Jews, compared to 48.6 to 244.44 in Arabs. Comparing cumulative density of the cohort with respective age-specific breast cancer incidence in the population yielded a highly significant correlation: Jews; r = .97, P < .0001 and Arabs: r = .86, P = .007. A strong association was found between the log of cumulative density and the log of cancer incidence, as well. Our study identified correlations between cumulative mammographic density and breast cancer incidence in two distinct populations. The findings should prompt research to enhance our understanding of the pathogenesis of breast cancer, and lead to novel insights into measures of prevention.
- 9 March 2022
- Published by Wiley in International Journal of Cancer
- Vol. 150 (12) , 1968-1977
Correlation between cumulative mammographic density and age‐specific incidence of breast cancer: A biethnic study in Israel
Women with the most extensive breast density, have a 4- to 6-fold higher cancer risk than women with the lowest density. This cross-sectional study evaluated associations of cumulative mammographic density in two distinct ethnic groups with the respective age-specific breast cancer incidences in the population. The study compared four cohorts of 200 women each aged 35 to 49 and 50 to 74, representing Jewish and Arab ethnicity. Breast density measures were calculated from screening mammograms, using a thresholding software (Cumulus). Breast cancer specific incidence values were obtained from the National Cancer Registry. The percent mammographic density was lower for women aged 50 to 74 than 35 to 49 years, both for Jews: 11.7 vs 23.1 and for Arabs: 11.6 vs 18.3. In contrast, the cumulative density increased with age, from 37.30 to 181.24 in Jews, compared to 21.26 to 108.03 in Arabs. Similar trends in breast cancer incidence rates per 100 000 in the Israeli population were apparent, with an increase from 92.95 to 381.91 in Jews, compared to 48.6 to 244.44 in Arabs. Comparing cumulative density of the cohort with respective age-specific breast cancer incidence in the population yielded a highly significant correlation: Jews; r = .97, P < .0001 and Arabs: r = .86, P = .007. A strong association was found between the log of cumulative density and the log of cancer incidence, as well. Our study identified correlations between cumulative mammographic density and breast cancer incidence in two distinct populations. The findings should prompt research to enhance our understanding of the pathogenesis of breast cancer, and lead to novel insights into measures of prevention.
- 1 May 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (6) , 1929-1930
In CRC Screening, Timing Is Almost Everything
- 1 May 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (6) , 1929-1930
In CRC Screening, Timing Is Almost Everything